Progranulin modulator-1
Progranulin modulator-1 (Compound 60) is an orally active enhancer of progranulin (PGRN) secretion. Progranulin modulator-1 enhances the potency of BV-2 cell to increase PGRN levels, has inhibitory effect on hERG and Low cytotoxicity, the PGRN EC50 and hERG IC50 were 83 and 3100 nM, respectively.
For research use only. We do not sell to patients.
- CAS No.: 2641013-11-6
- Formula: C21H21F2N3O
- Molecular Weight:369.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
EC50: 83 nM (PGRN); IC50: 3100 nM (hERG)
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BV-2 | EC50 |
83 nM
Compound: 60
|
Induction of progranulin secretion in mouse BV-2 cells
Induction of progranulin secretion in mouse BV-2 cells
|
[PMID: 36368496] |
In Vitro
Progranulin modulator-1 (Compound 60) has an efflux ratio (ER) value <2, indicating that it is not a substrate for MDR and shows high brain tissue binding and high metabolic stability[1].
Progranulin modulator-1 In vitro ADME properties for selected molecules[1]
| MDCK-MDR1 PappA→B [ER] | Protein Binding, Fu | Brain Tissue Binding, Fu | Hepatocytes t1/2 , CLint |
| 0.53 [1.11] | 3.1 (m); 5.5 (h) | 0.9 (m) | >120, <68.2 (m); >120, <14.7 (h) |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Pharmacokinetic Parameters for Progranulin Modulator-1 in Mouse[1]
| PO t1/2 (h) | IV t1/2 (h) | Cmax,u (nM) | Kpuu @ 8 h | F (%) | CL | Vdss |
| 4.8 | 7.4 | 62 | 2.91 | 99 | 2.08 | 15.2 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2641013-11-6
-
Molecular Weight 369.41
-
Formula C21H21F2N3O
-
SMILES
FC1=CC=C(C=C1)[C@@H]2N(C3=N[C@H](C4(CNC4)F)CO3)CCC5=CC=CC=C52
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)